Swissmedic and the veterinary pharmaceutical industry meet regularly to discuss topics relating to the regulation of medicinal products at a Round Table on VMP (referred to below as the "Round Table”). The Round Table enables the parties to make their concerns heard in order to respond promptly and appropriately to regulatory and technical signals, as necessary. There are cases in which Swissmedic needs to discuss a change in the regulation of medicinal products with representatives of the veterinary pharmaceutical industry before the change is made, so that practical aspects of operational implementation can be properly taken into account and communicated appropriately to the target audience.
The Round Table comprises representatives of the veterinary pharmaceutical industry and its associations plus senior representatives of the Authorisation division at Swissmedic. Over the years, the direct exchange between Swissmedic and the veterinary pharmaceutical industry has proved to be a productive way of promoting mutual understanding of the parties’ concerns as well as for planning and implementing regulatory, process-related and technical changes in an efficient manner.
The Round Table’s guidelines for cooperation are set out in the Terms of Reference.
Industry participants
A maximum of 12 representatives of the veterinary pharmaceutical industry who are familiar with operational issues in the industry on the basis of their day-to-day work or many years of experience will take part in the Round Table. They will also need to have in-depth knowledge of the legislation, the political environment and the working methods of Swissmedic.
The associations will agree among themselves on their representatives at the Round Table. If you are interested in taking part, please first contact anfragen@swissmedic.ch
The following people currently participate in the VMP Round Table:
| Name |
Company / Association |
| Dr. med. vet. Pascal Winkler |
Technical Director, Arovet AG |
| Dr. med. vet. Susanne Hofstetter |
Senior Manager Regulatory Affairs and Quality Assurance, FvP, Vétoquinol AG |
| Dr. Yolanda Käser |
Head Regulatory Affairs & Quality Operations, FVP/QP, Zoetis Schweiz AG |
| Dr. med. vet. Jessica von Hof |
Head of Medical Science, ufamed AG |
| Andrea Mundt |
Regulatory Affairs Manager Animal Health, Boehringer Ingelheim (Schweiz) GmbH |
| Dr. med.vet. Nicole Coati |
Regulatory Affairs Manager DACH (Switzerland) Elanco Tiergesundheit AG |
| Dr. med. vet. Mina Gómez Góngora |
Director Development & Registration, Dr. E. Graeub AG |
| Dr. med. vet. Bernward Zeeh |
Regulatory Affairs Manager, Henry Schein Animal Health |
| Dr. Ursula Jost |
Regulatory Affairs Manager, MSD Animal Health GmbH |
| Med. vet. Nadine Studer |
Regulatory Affairs & Quality Assurance Manager
Virbac Schweiz AG |
| lic. iur. RA Jürg Granwehr |
scienceindustries |
| Jean Claude Barandun, M.A. Pol. Sc. |
Wissenschaftlicher Mitarbeiter Pharma & Recht, scienceindustries |
| Annika Rothe |
Regulatory Affairs Manager, Streuli Pharma AG |
